90 related articles for article (PubMed ID: 2065284)
1. Breast cancer with bone-only metastases. Visceral metastases-free rate in relation to anatomic distribution of bone metastases.
Yamashita K; Ueda T; Komatsubara Y; Koyama H; Inaji H; Yonenobu K; Ono K
Cancer; 1991 Aug; 68(3):634-7. PubMed ID: 2065284
[TBL] [Abstract][Full Text] [Related]
2. Osseous metastatic pattern in breast-cancer - relation between anatomical distribution and ulterior visceral involvement.
Vallejo C; Perez J; Rodriguez R; Cuevas M; Machiavelli M; Lacava J; Romero A; Rabinovich M; Leone B
Oncol Rep; 1994 Mar; 1(2):357-9. PubMed ID: 21607365
[TBL] [Abstract][Full Text] [Related]
3. The use of serial bone scans in assessing response of bone metastases to systemic treatment.
Citrin DL; Hougen C; Zweibel W; Schlise S; Pruitt B; Ershler W; Davis TE; Harberg J; Cohen AI
Cancer; 1981 Feb; 47(4):680-5. PubMed ID: 6261915
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.
Jacobson AF; Shapiro CL; Van den Abbeele AD; Kaplan WD
Cancer; 2001 Jan; 91(1):17-24. PubMed ID: 11148555
[TBL] [Abstract][Full Text] [Related]
5. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis.
Solomayer EF; Diel IJ; Meyberg GC; Gollan C; Bastert G
Breast Cancer Res Treat; 2000 Feb; 59(3):271-8. PubMed ID: 10832597
[TBL] [Abstract][Full Text] [Related]
6. Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer.
Crippa F; Bombardieri E; Seregni E; Castellani MR; Gasparini M; Maffioli L; Pizzichetta M; Buraggi GL
J Nucl Biol Med (1991); 1992; 36(1):52-5. PubMed ID: 1450226
[TBL] [Abstract][Full Text] [Related]
7. Cost efficiency of bone scans in breast cancer.
Kennedy H; Kennedy N; Barclay M; Horobin M
Clin Oncol (R Coll Radiol); 1991 Mar; 3(2):73-7. PubMed ID: 1903301
[TBL] [Abstract][Full Text] [Related]
8. Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer.
Yang SN; Liang JA; Lin FJ; Kao CH; Lin CC; Lee CC
J Cancer Res Clin Oncol; 2002 Jun; 128(6):325-8. PubMed ID: 12073051
[TBL] [Abstract][Full Text] [Related]
9. Association between number and sites of new bone scan abnormalities and presence of skeletal metastases in patients with breast cancer.
Jacobson AF; Stomper PC; Jochelson MS; Ascoli DM; Henderson IC; Kaplan WD
J Nucl Med; 1990 Apr; 31(4):387-92. PubMed ID: 2324816
[TBL] [Abstract][Full Text] [Related]
10. Bone metastases in primary operable breast cancer. The role of serial scintigraphy.
Thomsen HS; Lund JO; Munck O; Andersen KW; Støckel M; Rossing N
Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1019-23. PubMed ID: 6540684
[TBL] [Abstract][Full Text] [Related]
11. Relation between pain and skeletal metastasis in patients with prostate or breast cancer.
Levren G; Sadik M; Gjertsson P; Lomsky M; Michanek A; Edenbrandt L
Clin Physiol Funct Imaging; 2011 May; 31(3):193-5. PubMed ID: 21114613
[TBL] [Abstract][Full Text] [Related]
12. Value of baseline and follow-up whole-body bone scans in detecting bone metastasis in high-risk breast cancer patients.
Al-Muqbel KM; Yaghan RJ
Nucl Med Commun; 2013 Jun; 34(6):577-81. PubMed ID: 23542913
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the prognosis of cancer patients with metastatic bone tumors based on serial bone scintigrams.
Ohmori K; Matsui H; Yasuda T; Kanamori M; Yudoh K; Seto H; Tsuji H
Jpn J Clin Oncol; 1997 Aug; 27(4):263-7. PubMed ID: 9379516
[TBL] [Abstract][Full Text] [Related]
14. Healing flare in skeletal metastases from breast cancer.
Janicek MJ; Hayes DF; Kaplan WD
Radiology; 1994 Jul; 192(1):201-4. PubMed ID: 8208938
[TBL] [Abstract][Full Text] [Related]
15. Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer.
Gandaglia G; Karakiewicz PI; Briganti A; Passoni NM; Schiffmann J; Trudeau V; Graefen M; Montorsi F; Sun M
Eur Urol; 2015 Aug; 68(2):325-34. PubMed ID: 25108577
[TBL] [Abstract][Full Text] [Related]
16. Predictors of a positive baseline bone scan in breast cancer.
Ho YY; Chan YH
Australas Radiol; 2005 Feb; 49(1):21-6. PubMed ID: 15727605
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark.
Cronin-Fenton D; Kjærsgaard A; Nørgaard M; Amelio J; Liede A; Hernandez RK; Sørensen HT
Breast Cancer Res Treat; 2018 Jan; 167(2):517-528. PubMed ID: 28948396
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer.
Montravers F; Younsi N; Rousseau C; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN
Anticancer Res; 1997; 17(3B):1683-6. PubMed ID: 9179218
[TBL] [Abstract][Full Text] [Related]
19. Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients.
Zissimopoulos A; Matthaios D; Matthaiou E; Mantadakis E; Karaitianos I
J BUON; 2007; 12(4):505-11. PubMed ID: 18067209
[TBL] [Abstract][Full Text] [Related]
20. The distribution of skeletal metastases in breast and pulmonary cancer: concise communication.
Wilson MA; Calhoun FW
J Nucl Med; 1981 Jul; 22(7):594-7. PubMed ID: 7252563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
